Abstract:OBJECTIVE:To study the effects of RNA interference (RNAi)-mediated insulin-like growth factor I receptor (IGF-IR) gene silencing on human lung cancer cells. METHODS:Plasmids expressing IGF-IR shRNA1 and IGF-IR shRNA2 were constructed. Human non-small cell lung cancer cells of the line A549 were cultured and transfected with sequence-specific shRNA. RT-PCR was used to monitor the IGF-IR mRNA expression. Western blotting was used to detect the expression of IGF-IR, bcl-2 and caspase-3, associated with apoptosis, and IGF-IR signaling pathways-associated proteins, total and phospho-ERK1/2 and Akt. MTT assay and flow cytometry were used to examine the cell activity and cell cycle. Twelve nude mice were injected subcutaneously with A549 cells, 20 days later the mice were randomly divided into 3 groups to be injected into the tumor with IGF-IR, PBS, or blank plasmid respectively 4 times with the interval of 5 days. Five days after the 4th injection the mice were killed and the tumors were taken out. TUNNEL assay was used to detect the apoptotic cell in the tumor. RESULTS:RT-PCR showed that the IGF-IR mRNA expression level of the A549 cells transfected with IGF-IR shRNA1 was only 24% +/- 4% that of the A549 cells transfected with blank plasmid (P < 0.05); however, the IGF-IR mRNA expression level of the A549 cells transfected with IGF-IR shRNA2 was 78% +/- 5% that of the A549 cells transfected with blank plasmid (P > 0.05). The IGF-IR protein expression level of the A549 cells of the IGF-IR shRNA1 group was only 10.2% +/- 2.8% that of the A549 cells of the blank plasmid group (P < 0.05). Western blotting showed that the protein expression levels of bcl-2 and caspase-3p20 of the A549 cells of the IGF-IR shRNA1 group were 46% +/- 6% and 156% +/- 8% those of the negative controls (both P < 0.05); however, the protein expression levels of bcl-2 and caspase-3p20 of the A549 cells of the IGF-IR shRNA2 group were not different from those of the negative control cells. The Akt kinase and ERK phosphorylation levels of the A549 cells of the IGF-IR shRNA1 group were 10% and 36% +/- 3% those of the negative control cells respectively (both P < 0.05). Since 48h after the transfection the active cell number of the IGF-IR shRNA1 group was 64% +/- 7% that of the negative group (P < 0.05), and this decrease effect lasted to 72 h after (67% +/- 6% that of the negative cells, P < 0.05). 48 h after the transfection the percentage of cells at G(0)/G(1) phase of the IGF-IR shRNA1 group was 77.5%, significantly higher than that of the negative control group, and the percentages of the cells at S and G(2)/M phases of the IGF-IR shRNA1 group were 15.7% and 7.3% respectively, both significantly lower than those of the negative control group (23.0% and 29.9% respectively). Since the second injection the tumor size of the mice of IGF-IR shRNA group was 40% - 50% that of the PBS group (P < 0.05), and the tumor size of the mice of the PBS group was 90% that of the control group. TUNNEL assay showed that the number of apoptotic cells in the tumors of the IGF-IR shRNA1 group mice was 118 +/- 8/high power, significantly higher than that of the control group (70 +/- 9, P < 0.05). CONCLUSION:RNAi technique effectively inhibits the expression of IGF-IR, thus decreasing the NSCLC cell proliferation inducing apoptosis and inhibiting the tumor growth.

Effect of Inflammatory Factors on Cell Proliferation and Apoptosis in Insulin-like Grown Factor 1-slienced Human Coronary Artery Smooth Muscle Cells

Expression of PAPP-A, IGF-I and Their Effects on the Cytological Functions of Sirna Lentiviral Vector of Hcasmcs IGF-I after Inflammatory Factor

Effects of Insulin-Like Growth Factor-1 on the Proliferation, Apoptosis and MAPK Signaling Pathway of Rat Colonic Smooth Muscle Cells

Influences of Over-Expression of VEGF-C and Its Inhibition on Biological Characteristics of NCI-H446 Human Small-Cell Lung Cancer Cells

Effect of Insulin-Like Growth Factor-1 on Hyperoxia-Induced Apoptosis in A549 Cells

Effects of IGF-II on promoting proliferation and regulating nitric oxide synthase gene expression in mouse osteoblast-like cell

Effect of adipose-derived stem cells modified by insulin-like growth factor I gene on TWEAK/Fn14 signaling pathway

Effect of Insulin-Like Growth Factor-ⅰ(Igf-ⅰ)on Apoptosis of Colon Cancer Cell and Its Mechanism

Effect of IGF1R gene silencing on the proliferation and apoptosis of human adreno-cortical carcinoma cell line SW13

The promoting effects of insulin-like growth factor 1 on the biological behaviour of human retinal vascular endothelial cells

[Effects of Insulin Like Growth Factor-1 on Cell Viability and Tissue Factor in Vascular Endothelial Cells].

Effect of RNAi-mediated IGF1R gene silencing on growth, migration, and invasion of hepatocellular carcinoma cells

Insulin-like Growth Factor-1 Inhibits the Apoptosis of Rat Gastric Smooth Muscle Cells Cultured under High Glucose Condition Through PI3K-Akt-PKC-Ca2+pathway

Role of Insulin-Like Growth Factor-1 (IGF-1) in Regulating Cell Cycle Progression

Effect of Silencing Hypoxia Inducible Factor 1α by siRNA on The Expression of Stromal Cell Derived Factor 1α in Fetal Liver Stroma Cell

[Shrna-Mediated Insulin-Like Growth Factor I Receptor Gene Silencing Inhibits Cell Proliferation, Induces Cell Apoptosis, and Suppresses Tumor Growth in Non-Small Cell Lung Cancer: in Vitro and in Vivo Experiments].

Effects of Lentivirus-Mediated Sirna Targeting IGF-1R on Migration and Invasion Abilities of Endometrial Carcinoma Cells

Insulin-like Growth Factor-1 Receptor Activation Prevents Hydrogen Peroxide-Induced Oxidative Stress, Mitochondrial Dysfunction and Apoptosis

Effects of Insulin-1Ike Growth Factor 1 and Its Receptor on Proliferation of Ovarian Cancer Cells

Insulin-Like Growth Factor 1 Treatment of MSCs Attenuates Inflammation and Cardiac Dysfunction Following MI

Effect of insulin like growth factor binding protein 3 on non-small cell lung cancer